Membrane type 1-matrix metalloproteinase (MT1-MMP), a membrane-tethered protease, is key for matrix breakdown during cancer invasion and metastasis. Assembly of branched actin networks by the Arp2/3 complex is required for MT1-MMP traffic and formation of matrix-degradative invadopodia. Contrasting with the well-established role of actin filament branching factor cortactin in invadopodia function during cancer cell invasion, the contribution of coronin-family debranching factors to invadopodia-based matrix remodeling is not known. Here, we investigated the contribution of coronin 1C to the invasive potential of breast cancer cells. We report that expression of coronin 1C is elevated in invasive human breast cancers, correlates positively with MT1-MMP expression in relation with increased metastatic risk and is a new independent prognostic factor in breast cancer. We provide evidence that, akin to cortactin, coronin 1C is required for invadopodia formation and matrix degradation by breast cancer cells lines and for 3D collagen invasion by multicellular spheroids. Using intravital imaging of orthotopic human breast tumor xenografts, we find that coronin 1C accumulates in structures forming in association with collagen fibrils in the tumor microenvironment. Moreover, we establish the role of coronin 1C in the regulation of positioning and trafficking of MT1-MMP-positive endolysosomes. These results identify coronin 1C as a novel player of the multi-faceted mechanism responsible for invadopodia formation, MT1-MMP surface exposure and invasiveness in breast cancer cells.
Introduction
Tumor cell escape and dissemination to distant sites are hallmarks of metastasis, the leading cause of cancer-related death. During breast cancer progression, a key step is the transition from ductal carcinoma in situ (DCIS)-a mass of proliferative cells inside the mammary duct surrounded by an intact myoepithelium and by the basement membrane (BM)-to invasive breast cancers. DCIS-to-invasive breast cancer transition is associated with breakdown of the myoepithelium and the underlying BM and increased metastasis risk. The capacity of cancer cells to remodel extracellular matrix (ECM) barriers is essential for cancer progression and metastasis [1] . Proteolytic remodeling of ECM components by cancer cells mobilizes a group of transmembrane matrix metalloproteinases (MMPs), which includes membrane type 1 (MT1)-MMP (aka MMP14) [1] . We recently reported that MT1-MMP is up-regulated in invasive hormone receptor-and epidermal growth factor receptor 2 (HER2)-negative triple-negative breast cancers (TNBCs) as compared to DCIS lesions and normal breast tissue and overexpression predicts the invasive potential of cancerous lesions [2] .
Experimental data based on cancer cell models revealed that ECM remodeling by carcinomatous cells is focused to the pericellular zone [3, 4] . Matrix gaps and tunnels forming overtime support infiltrating cell passage through the BM and through the fibrous collagen microenvironment [3] . ECM breakdown is mediated by specialized cellular structures of metastatic cells called invadopodia, which form at the plasma membrane in association with ECM fibrils and require actin assembly for their formation [5] . Invadopodia are the sites of surface exposure and accumulation of MT1-MMP [6] [7] [8] . Due to difficulties inherent to the submicrometric size and transient nature of invadopodia, fewer studies addressed their formation, dynamics, and structure in vivo. However, recent work based on emerging intravital microscopy technics, reported the existence of invadopodialike protrusions in relation with matrix remodeling and metastasis in the natural tumor microenvironment [9, 10] .
Polymerization of invadopodial actin is a multistep process that requires activation of the Arp2/3 complex by nucleation promoting factor Wiskott-Aldrich syndrome like protein (N-WASP) [11] . Regulators of branched actin network dynamics including cortactin (CTTN) and cofilin are likewise essential for invadopodia formation [6, 12] . The actin-binding protein CTTN promotes actin network assembly by facilitating N-WASP displacement from Arp2/ 3 complex and stabilizing Arp2/3 complex at branches [13, 14] . Moreover, CTTN promotes branch stabilization by antagonizing members of the WD40 domain-containing Factin binding coronin family members, which control debranching and Arp2/3-nucleated filament network disassembly [15] [16] [17] . Additionally, coronins bind to and inhibit nucleation by the Arp2/3 complex [15, 18, 19] . All together, these data point to some coordinated functions of CTTN and coronin in the regulation of branched actin network assembly and dynamics.
In carcinoma cells, altered phosphorylation and upregulation of CTTN are associated with increased invadopodia density, promoting invasion and tumor aggressiveness [12, [20] [21] [22] [23] [24] . Similarly, the coronin-family protein coronin 1C (CORO1C aka coronin-3, CRN2) is upregulated in human cancers including gastric cancers, hepatocellular carcinomas, and brain tumors and is correlated with increased invasiveness and metastasis [24] [25] [26] [27] [28] . In addition, experimental data have shown that CORO1C is required for degradation of gelatin as a matrix mimic and for formation of invasive protrusions by human glioblastoma cells [28, 29] .
Convergent observations in carcinoma cell lines have identified a pathway involving late endosome (LE)/lysosome compartments in returning internalized MT1-MMP to invadopodia forming at plasma membrane/ECM contact sites [7, 8, 23, [30] [31] [32] . Docking of MT1-MMP-positive LE/ lysosomes to the invadopodial plasma membrane allows surface exposure of the protease possibly through the formation of tubular connections between the limiting membrane of LE/lysosomes and the plasma membrane [8, 32, 33] . The pathological relevance of this recycling circuitry has been recently established in the context of the invasion program of TNBCs [23, 31, 32] . A characteristic feature of this mechanism is the presence of F-actin/CTTNenriched puncta on MT1-MMP-positive LE/lysosomes, which depend on the Arp2/3 complex and its activator WASH complex for their formation [8, 23, 34, 35] . Perturbation of WASH function affects endolysosomal F-actin/ CTTN puncta, interferes with the trafficking of MT1-MMP vesicles to the invadopodial plasma membrane and inhibits MT1-MMP surface exposure and invasion [8, 32] . Interestingly, a study in macrophages has provided evidence for a role of coronin 1A (CORO1A) in controlling endolysosomal actin assembly in the context of cholesterol trafficking and clearance [36] . In addition, coordinated functions of CTTN and coronin 1B (CORO1B aka coronin-2) have been implicated in trafficking and plasma membrane docking of multivesicular LEs and regulation of exosome secretion from these compartments in conjunction with the small GTPase Rab27a function [37, 38] . All together, these data suggest some cooperative functions of CTTN and coronins in the regulation of endolysosomal actin dynamics and trafficking and exocytosis of LE/lysosomal cargo proteins including MT1-MMP.
Here we show that CORO1C is up-regulated in invasive breast cancers and correlates positively with MT1-MMP expression in TNBCs in relation with poor prognosis. Additionally, our results indicate that CORO1C plays a dual function in MT1-MMP-dependent pericellular matrix degradation by regulating invadopodia formation and by controlling the positioning of MT1-MMP storage endolysosomes.
Results

CORO1C is associated with poor outcome in breast cancer
Expression of CORO1A, -B, and -C type I coronin family members and pro-invasive MT1-MMP was analyzed by immunoblotting in a panel of 30 breast cancer cell lines. These cell lines were stratified in normal-like, luminal, TNBC and HER2
+ subtypes based on the expression patterns of estrogen and progesterone receptors (ER and PR) and HER2 amplification [39] . Expression of hematopoieticspecific CORO1A was detected in Jurkat leukemic T-cells, while levels were low to barely detectable in the breast cancer cell lines (Fig. 1a, b) . In contrast, CORO1B expression was detected in most breast cancer cell lines irrespective of subtypes (Fig. 1a, c) . Expression of CORO1C was mostly restricted to TNBC cells similar to MT1-MMP expression pattern (Fig. 1a, d , e). Expression of CORO1B and CORO1C mRNAs was analyzed by quantitative RT-PCR in invasive breast cancers using a Fig. 1 Patients displaying high CORO1C and MT1-MMP mRNA expression have poor outcomes in breast cancer. a Whole-cell lysates from human breast carcinoma cell lines and Jurkat T cells were normalized for protein concentration and immunoblotted with indicated antibodies. Stratification of breast cancer cell lines in normal-like, TNBC, luminal and HER2 subtypes was according to [39] .
b-e Expression of the indicated proteins in the different cell lines divided in four subtypes was normalized to GAPDH level. Protein levels were analyzed in two to three experiments for each protein in each cell line and plots correspond to average expression levels±SEM in each subtype. f Expression of the indicated genes was analyzed by RT-qPCR in 446 mRNA tumor samples. Patients exhibiting high CORO1C mRNA have reduced MFS (log-rank test using optimal cutoff of 1.52; P = 0.00082). Number of patients in each subgroup is indicated in parenthesis. g Correlation between indicated gene transcripts was analyzed using the Spearman's rank correlation test (in bold type). P values are in italics. h Patients exhibiting both high CORO1C and MT1-MMP mRNAs have reduced MFS (log-rank test using optimal cut-off of 1.52 for CORO1C and 1.30 for MT1-MMP; P = 0.00048) retrospective cohort of 446 patients with long-term followup. It allowed us to examine if variations in CORO1B and -C mRNA expression had a value for patient prognosis (Table S3) . We found that 12.1% of breast tumors overexpressed CORO1B mRNA (>3 relative to normal tissues, not shown). Highest CORO1B expression levels were observed in HER2 tumors and positively correlated with Ki-67 proliferation marker (Table S4) . However, we did not see an impact of CORO1B expression on the metastasis-free survival (MFS) of breast cancer patients (not shown).
Tumors expressing high levels of CORO1C showed more often ER and PR negativity, correlated with high Ki-67 and epidermal growth factor receptor (EGFR) levels and were more frequently of an advanced grade indicative of an association with bad prognosis (Table S5) . Most importantly, CORO1C up-regulation was associated with significantly shorter MFS (Fig. 1f) . Multivariate analysis using a Cox proportional hazard model revealed independent predictive value for MFS of lymph node status, tumor size and grade, and CORO1C mRNA expression parameters, indicating that CORO1C expression is a new independent prognostic factor in breast cancer (Table S6 , P = 0.0029).
Based on available RT-qPCR data in the same cohort [2] , we found a strong positive correlation of CORO1C and MT1-MMP mRNAs (Fig. 1g) . Correlation of CORO1C and MT1-MMP expression was similarly observed at the protein level by immunoblotting analysis of a subset of tumor samples selected based on low and high mRNA levels; while there was no obvious correlation with CORO1B or CTTN expression in these tumor samples (Fig. S1AB) . Importantly, we analyzed the association of CORO1C and MT1-MMP transcript levels with clinical outcome and found significantly increased metastatic risk in patients with both high MT1-MMP and CORO1C mRNA levels (Fig. 1h) . The prognostic significance of "MT1-MMP and CORO1C expression level" persisted in Cox multivariate regression analysis (Table S7 , P = 0.00007).
Next, we focused our study on CORO1C showing strongest correlation with pro-invasive MT1-MMP and previously implicated in cancer progression and metastasis [25, 26, 28] . Changes in CORO1C protein levels in epithelial cancer cells were investigated by immunohistochemistry (IHC) analysis of a tissue microarray (TMA) of invasive breast cancers and adjacent peritumoral tissues from an independent cohort of 136 patients (Table S8) . Specificity of CORO1C IHC staining was established by analysis of human MCF10DCIS.com breast cancer-derived cells knocked down for CORO1C expression (Fig. S1C) . In peritumoral epithelial tissues, we detected low cytoplasmic levels of CORO1C in luminal cells and strong expression in myoepithelial cells (Fig. 2a, b) . CORO1C staining was observed in the cytoplasm of breast carcinoma cells (Fig. 2a, b) . Quantification and analysis of CORO1C Hscore (intensity multiplied by percentage of positively stained cells) revealed significantly higher levels of CORO1C in invasive cancer relative to normal breast tissues (Fig. 2c ), in agreement with RNA expression data (Table S5 ) and protein analysis in breast cancer cell lines (Fig. 1a, d ). CORO1C levels were highest in TNBC subtype although difference with other subtypes was not statistically significant (Fig. 2d) . Therefore we concluded that CORO1C expression was up-regulated in invasive breast cancers at the mRNA and protein levels, particularly in TNBCs and correlated with worse prognosis and increased metastasis risk in association with MT1-MMP up-regulation. At the mechanistic level, these data suggested some involvement of CORO1C in MT1-MMP-dependent pericellular ECM proteolysis activity during breast tumor progression and dissemination.
CORO1C is required for invadopodia function and tumor cell invasion GFP CORO1C was stably overexpressed in MDA-MB-231 cells used as a TNBC model (Fig. S2A ). These cells invaded through the 3D fibrous type I collagen network with an elongated morphology typical of this highly invasive mesenchymal cell line (Fig. 3a , low magnification inset and Supplementary Movie S1). CTTN and GFP CORO1C colocalized in lamellipodia at the edge of invasive protrusions extending within the collagen gel (Fig. 3a , low magnification inset). In addition, arc-shape structures enriched for CTTN and CORO1C were visible in association with collagen fibrils in front of the nucleus, which was located at the rear of the cell (Fig. 3a, inset 1) . Strong pericellular collagenolysis was observed in association with the bulbous nuclear cell region as revealed by staining for neoepitope of MMP-cleaved type I collagen (Fig. 3b, yellow) . When cells were plated on top of a 2D layer of collagen fibrils, CORO1C was similarly found at the cell edge as well as in curvilinear structures forming in association with the underlying collagen fibrils, which were positive for the invadopodia protein TKS5 (Fig. 3c) [8, 40] . Collectively, our observations indicated that CORO1C accumulated at proteolytically active invadopodia forming in association with confining collagen fibrils.
The effect of GFP CORO1C overexpression on the invasive capacity of MDA-MB-231 cells in 3D collagen was assessed. Multicellular spheroids of MDA-MB-231 cells overexpressing GFP or GFP CORO1C were formed and embedded in the type I collagen gel and invasion was monitored after 2 days. Overexpression of GFP CORO1C significantly increased the invasive potential of MDA-MB-231 cells in the 3D collagen gel (Fig. 3d, e) . CORO1C-dependent invasion required MMP activity as shown by inhibition in the presence of generic GM6001 MMP inhibitor (Fig. 3e) . The proinvasive potential of CORO1C was generalized using multicellular spheroids of human MCF10DCIS.com cells overexpressing GFP CORO1C or YFP as a control (Fig. S3AB ).
Actin polymerization is essential for invadopodia formation and function and CORO1C is known to regulate branched actin dynamics. We therefore investigated the contribution of CORO1C to the formation of TKS5-positive invadopodia in MDA-MB-231 cells plated on top of a collagen fibril layer as in Fig. 3c . Overexpression of CORO1C increased significantly the formation of TKS5-positive invadopodia (Fig. 3f) . GFP CORO1C R28D/2KE harboring the R28D, K418E, K419E, K427E, and K428E mutations, which is defective for F-actin binding [41] , was diffusely distributed, indicating that CORO1C association to invadopodia required binding to F-actin similar to CORO1B and -C recruitment to the lamellipodia [41, 42] (Fig. S3C) . Remarkably, actin-binding deficient COR-O1C R28D/2KE exerted a dominant inhibitory effect on invadopodia formation (Fig. 3f ). An equivalent mutation in CORO1B has been shown to affect F-actin binding but no other molecular interactions [15, 42] , which may explain the observed dominant inhibitory potential by titration of important functional partners. In addition, CORO1C was knocked-down by treatment with two independent siRNAs C neoepitope staining by indicated cell populations normalized to GFPexpressing (I) or siNT-treated (j) control cells ± SEM; n, number of cells analyzed from three independent experiments. Data were transformed using the log transformation y = log(y) to make data conform to normality and analyzed using one-way ANOVA leading to >95% silencing of the protein with no effect on MT1-MMP or TKS5 levels (Fig. S2C) . Loss of CORO1C expression reduced by 50-60% the capacity of MDA-MB-231 cells to form TKS5-positive invadopodia in association with the collagen fibrils ( Fig. 3g and Fig. S3DE ). CORO1B knockdown similarly decreased the formation of TKS5-positive invadopodia by~50% (Fig. 3g and Fig. S2D ). Loss of both CORO1B and CORO1C did not further reduce invadopodia formation, suggesting that the two isoforms may function together as recently reported [17] (Fig. 3g) . Along this line, we found that overexpressed CORO1B GFP accumulated together with MT1-MMP mCh in invadopodia forming in association with collagen fibers (Fig. 3h, inset 1 and Fig. S2B) .
Consequences of modulation of CORO1C expression on pericellular matrix degradation in 3D collagen were analyzed by staining of cleaved collagen. Collagen proteolysis mediated by MT1-MMP was strongly up-regulated upon CORO1C overexpression, while ECM degradation was inhibited by CORO1C R28D/2KE or CORO1C silencing (Fig. 3i-k) . Collectively, these data indicated that CORO1C had a significant contribution to invadopodia formation and to the invasive program of TNBC cells.
We found that CORO1C co-localized with CTTN at invadopodia (Fig. 3a) . Using the same assays, we observed that CTTN knockdown strongly decreased 3D collagen invasion of MDA-MB-231 multicellular spheroids similar to the silencing of MT1-MMP and CORO1C (Fig. S4A-C) . In addition, knockdown of CTTN also correlated with a strong reduction of pericellular collagen degradation (Fig.  S4DE) . Thus, we concluded that up-regulation of CORO1C expression promoted the invasive potential of TNBC by favoring the formation of proteolytically active invadopodia, and that CORO1B/1C and CTTN contributed to invadopodia activity, suggesting some cooperative function.
CORO1C puncta are observed in association with collagen fibers in breast tumor cells in vivo
Our data identified CORO1C as a key invadopodia component of invasive MDA-MB-231 cells. In agreement with CORO1C requirement during collective invasion by epithelial MCF10DCIS.com breast cancer cells (Fig. S3AB) , we also observed a strong association of GFP CORO1C with TKS5-positive proteolytically active invadopodia forming in association with collagen fibrils in this cell line (Fig.  S5A-C) . Thus, the distribution of GFP CORO1C, which localized to invadopodia in breast cancer cells was investigated in vivo. We used intravital imaging of mammary MDA-MB-231 and MCF10DCIS.com cell tumor xenografts to visualize GFP CORO1C in relation with the tumor ECM microenvironment. MDA-MB-231/ GFP CORO1C tumor xenografts growing in the mammary gland of SCID mice upon fat pad injection were imaged using 2-photon laser scanning intravital microscopy combined with second harmonic generation (SHG) to visualize collagen fibrils (Fig. 4a) . Accumulations of GFP CORO1C were visible in tumor cells adjacent to collagen fibers (Fig. 4a-c , arrows and insets 1-3). These structures were morphologically heterogeneous ranging from small (submicrometric) puncta ( Fig. 4b and insets 1, 2) to several μm-long linear structures similar to curvilinear invadopodia observed in tumor cell lines in vitro (Fig. 4c and inset 3) . Contrastingly, intravital imaging of fat pad tumors of MDA-MB-231 cells expressing GFP CORO1C R28D/2KE revealed a diffuse cytosolic distribution of the actin-binding defective CORO1C variant in tumor xenografts (Fig. 4d and inset 4) . Therefore, similar to our observations in cultured cells, accumulation of CORO1C in association with collagen fibers in vivo required F-actin binding capacity of CORO1C.
The distribution of CORO1C was similarly analyzed during the growth and invasion of MCF10DCIS.com tumor xenograft generated using the intraductal (nipple-) injection model [43] . We and others reported that injection of this cell line into the duct lumen in SCID mice leads to the formation of DCIS tumor xenografts, which can further progress into invasive lesions upon BM breaching depending on MT1-MMP activity [2, 43] . Stable overexpression of GFP CORO1C did not affect MCF10DCIS.com cell's growth in culture (Fig. S5D) . Whole-mount and tissue section staining of tumor xenografts analyzed 4-5 weeks after intraductal injection revealed the presence of large epithelial tumors growing within the mammary duct system of SCID mice injected with control or GFP CORO1C-overexpressing MCF10DCIS.com cells (Fig. S5E, F and H) . Tumors presented a necrotic center and some invasive foci of epithelial cells were visible within the mammary gland stroma (Fig. S5E, arrowhead) . Tumor burden (foci number and size) was increased in mammary glands injected with GFP CORO1C-overexpressing cells as compared to control MCF10DCIS.com cells, although differences were not statistically significant 4 to 5-weeks after injection (Fig. S5F-I ). These data suggested that GFP CORO1C overexpression conferred some growth advantage to MCF10DCIS.com epithelial tumors. Ductal GFP CORO1C-expressing tumor xenografts were analyzed by intravital 2-photon imaging of GFP and SHG signals. Intraductal tumors were detected as tumor mass surrounded by a thick bed of collagen bundles tangential to the duct (Fig. 4e, f) . Some microinvasive buds were visible consisting of few GFP CORO1C-overexpressing epithelial cells that migrated in collective manner within the type I collagen bed (Fig. 4e , f and insets 5 and 6). Invasion of GFP CORO1C cells progressed overtime in the collagen-enriched stroma (compare inset 5 and 6 acquired at 1-week time interval). Intravital imaging at later time point (7-weeks post injection) revealed frankly invasive tumor lesions ( Fig. 4g-i) . The presence of GFP CORO1C accumulations forming at the surface of tumor MCF10DCIS.com cells in contact with intratumoral collagen fibers was visible similar to MDA-MB-231 tumors (Fig. 4g-i and inset 7) . Collectively, these data indicated that CORO1C accumulated in structures reminiscent of ECM degradative invadopodia, which formed in association with collagen fibrils in the invasive breast tumor xenografts in vivo.
Loss of CORO1C causes MT1-MMP-positive LE/ lysosome mispositioning and collapse
We have shown that MT1-MMP trafficking to invadopodia depends on actin dynamics on endolysosomes [8, 23] . The distribution of GFP CORO1C was analyzed by live cell imaging by confocal microscopy in MDA-MB-231 cells expressing MT1-MMP mCh . As previously described, MT1-MMP mCh accumulated in vesicles that we previously identified as LE/lysosomes [7, 32] . In addition to GFP CORO1C localization to lamellipodia, we observed the accumulation of GFP CORO1C in dynamic and discrete puncta on a majority of MT1-MMP mCh -positive vesicles (Fig. 5a and Supplementary Movie S2). In contrast, F-actin-bindingdeficient GFP CORO1C R28D/2KE was diffuse and cytosolic (Fig. 5b) . Endosomal CORO1C-enriched puncta were also positive for CTTN, although a slight shift was visible between the localization of the two proteins in line with the distinct roles played by these proteins in the actin branching cycle [15, 17] (Fig. 5c, inset) . Similarly, CORO1B GFP -positive puncta were visible on MT1-MMP LE/lysosomes (Fig. 3h, inset 2) . Cryoimmunoelectron microscopy confirmed the association of GFP CORO1C-positive puncta on the cytosolic face of LE/lysosomes (Fig. 5d) . All together, these data revealed that CORO1C and CORO1B localized to endosomal actin-, CTTN-rich puncta, which depend on WASH and Arp2/3 complexes for their formation, and are implicated in MT1-MMP delivery to invadopodia in breast cancer cells [8, 23, 32, 34, 35] .
We went on analyzing the consequences of CORO1C knockdown on the distribution and morphology of MT1-MMP-positive LE/lysosomes. In control RNAi treated cells, MT1-MMP-positive LE/lysosomes were distributed throughout the cell, with a concentration in the central region of the cell (Fig. 5e, i, j) . In cells silenced for (Fig. S6C-E) CORO1C, MT1-MMP-positive LE/lysosomes were also predominantly localized to the cell center (Fig. 5f, i) . In addition, we observed that reduced expression of CORO1C resulted in a tight clustering of MT1-MMP-positive LE/ lysosomes in~70% of the cells (Fig. 5j) . We recently identified the scaffolding proteins, JIP4 and JIP3, as key players in MT1-MMP endosome positioning by linking LE/ lysosomes to the microtubule motors kinesin-1 and dynein/ dynactin [32] . As previously described [32] , depletion of JIP3 and JIP4 resulted in MT1-MMP endosome dispersion toward the cell periphery (Fig. 5g, i, j and Fig. S6A ). Remarkably, triple knockdown of JIP3/JIP4 and CORO1C partially restored some level of scattering of MT1-MMPpositive endosomes (Fig. 5h, i, j) . All together, these data suggested that tight clustering of MT1-MMP-positive LE/ lysosomes induced upon loss of CORO1C function required retrograde endosomal trafficking in a JIP3/JIP4-dependent manner. Cells expressing MT1-MMP mCh were fixed and stained for JIP4 and CTTN, and fluorescence signal associated with MT1-MMP mCh -positive compartments was quantified. As previously reported [32] , JIP4, which is predominantly cytosolic, was detected throughout the cytoplasm and in close proximity to CTTN-positive puncta on the cytosolic face of MT1-MMP endosomes (Fig. 6a and quantification in d, e, see also Fig. S6C -C" for lower magnification images). Quantification of fluorescence signal associated with clustered, enlarged MT1-MMP mCh -positive endosomal compartments in CORO1C-depleted cells revealed opposite effects on CTTN and JIP4 association, i.e., CTTN association was diminished, while JIP4 accumulated on MT1-MMP compartments as compared to siNT-treated cells (Fig. 6b, d , e and Fig. S6D-E') . Additionally, CTTN knockdown did not alter significantly the association of JIP4 with endosomal membranes (Fig. 6c, d , e and Fig. S6B and FF') .
We noticed that morphological changes observed in CORO1C-depleted cells including enlargement and perinuclear clustering of LE/lysosomal compartments were reminiscent of cellular alterations typical of Niemann-Pick disease type C (NPC). Indeed, cholesterol-enriched LEs cluster in the perinuclear area, as a consequence of defective LE/lysosome traffic and cholesterol clearance in cells of lysosomal storage disease patients including NPC cells [44] . After fixation, MDA-MB-231 cells treated with control siRNA were stained with the fluorescent cholesterolbinding probe filipin and scattered cholesterol-positive LE structures were observed (Fig. S6G) . Treatment of the cells with U18666A, a widely-used amphipathic steroid, which blocks exit of cholesterol from LE/lysosomes and recapitulates the NPC phenotype [45] , induced tight clustering of cholesterol-laden LE/Lysosomes in the perinuclear cell region (Fig. S6H) . Similarly, LE/lysosome clusters forming in CORO1C-depleted cells were strongly enriched for cholesterol indicative of defective cholesterol exit from the clustered endosomes (Fig. S6IJ) .
In order to get further insight at phenotypic alterations of MT1-MMP-positive compartments induced by loss of CORO1C function, MDA-MB-231 cells knocked down for CORO1C were analyzed by transmission electron microscopy. Fig. 6f shows the distribution of LE/lysosomes in control cells. CORO1C depletion caused various morphological alterations of LE/lysosomal compartments, which were enlarged, aggregated and fused together and accumulated osmiophilic materials including lamellar inclusions reminiscent of the NPC phenotype (Fig. 6g-i) . Collectively, these data indicated that CORO1C played a key role in MT1-MMP LE/lysosome positioning. Loss of CORO1C expression altered the association of JIP4 (and CTTN) on endosomal membranes resulting in LE/lysosome clumps in the perinuclear area possibly responsible for deficient recycling and surface exposure of MT1-MMP.
Discussion
Previous findings indicated that CORO1C, a member of the coronin family of highly conserved F-actin-binding proteins and regulators of branched actin networks, contributes to invasiveness and metastasis in several cancer types including glioblastoma, primary effusion lymphoma, and TNBC [24, [26] [27] [28] [29] 46] . In addition, CORO1C is a biomarker for invasive progression of hepatocellular carcinoma [25] . However, our understanding of the cellular and molecular mechanisms underlying the role of CORO1C in tumor invasion has remained limited.
Here, we analyzed the expression profile of CORO1C in breast cancer in relation with MT1-MMP, the protease responsible for pericellular matrix degradation by carcinoma cells with major implications in the invasive potential and progression of breast tumors [2, 47, 48] . In a panel of cell lines representative of the breast cancer molecular subtypes [39] , CORO1C protein expression was detected mainly in TNBC cells similar to MT1-MMP [2] . CORO1B was broadly expressed irrespective of the molecular subtypes, while expression of hematopoietic-specific CORO1A was low to undetectable [16] . Based on RT-qPCR analysis of a retrospective cohort of invasive breast cancers, we found that CORO1C transcript was up-regulated in breast cancers and was associated with hormone receptor-negativity, high grade and metastasis risk. In addition, co-upregulation of CORO1C and MT1-MMP also correlated with significantly higher metastases risk. "High CORO1C expression" was an independent prognostic factor of breast cancer in multivariate analysis and prognostic significance of "MT1-MMP and CORO1C expression level" persisted in Cox multivariate regression analysis. Likewise, IHC analysis of invasive breast cancer TMAs confirmed the upregulation of CORO1C in breast carcinoma at the protein level as compared to normal epithelial tissue. CORO1B mRNA was also up-regulated in a breast tumor subset, although with no impact on MFS. Similar to our findings in breast cancer, published data have correlated CORO1C expression with high-grade gliomas and liver cancers and poor prognosis in stomach cancers [25, 27, 28] , while no such correlation has been reported between CORO1B and cancer progression. In conclusion, our data, which extend a previous analysis of publicly accessible databases [46] , indicate that CORO1C is up-regulated in hormone receptornegative breast tumors and associates with poor outcome.
Several studies reported that coronins, including CORO1C, regulate lamellipodial branched actin network and CORO1C activity impinges on cell migration and invasion by cancer cells, including MDA-MB-231 TNBC cells in vitro [28, 29, 46, 49] . Moreover, CORO1C was associated with invasive cell protrusions and has been implicated in the degradation of the matrix mimic gelatin by human U373 glioblastoma-derived cells [28, 29] . In the present study, we observed that CORO1C co-localized with CTTN and TKS5 in matrix-degradative actin-based invadopodia forming in association with type I collagen fibrils in TNBC cells. Importantly, knockdown of CORO1C inhibited invadopodia formation, pericellular collagenolysis and invasive migration in 3D collagen in two TNBC cell models with distinct mesenchymal (MDA-MB-231) or epithelial (MCF10DCIS.com) features. Thus, our work indicates that CORO1C is required both for single-cell and collective invasion patterns. Association of CORO1B with invadopodia was also observed and CORO1B was required for invadopodia formation. Moreover, loss of both CORO1C and 1B did not further inhibited invadopodia formation, suggesting that both isoforms may function as a complex as previously shown [17] .
Actin polymerization is a key component of invadopodia-based invasion program by driving invasive cell protrusions through the matrix and maintaining tight apposition of surface-exposed MT1-MMP with confining ECM fibrils [4, 8] . In addition, binding of MT1-MMP cytosolic tail to the invadopodial actin network is thought to anchor MT1-MMP to these structures [50] . Assembly of invadopodial actin requires activation of the Arp2/3 complex by N-WASP [8, 11, 50 ]. An antagonism of CTTN and coronin functions has been proposed in the control of a cycle of Arp2/3 branch stabilization and destabilization ( [15] [16] [17] 51] and references herein). In addition, coronin and CTTN have been implicated in the regulation of cofilin activity in actin filament turnover, which is crucial during invadopodia assembly [11, 51] . We observed that CORO1B/1C and CTTN co-localized at invadopodia. Alike CORO1B/1C, CTTN has been identified as a key regulator of invadopodia formation and its overexpression in various cancer types is associated with tumor progression and metastasis [6, 12] . Here, we found that unbalanced CTTN and CORO1B/1C activity upon individual silencing (or inhibition) of either proteins impairs invadopodia formation and function, emphasizing complex and cooperative functions of CTTN and CORO1B/1C in the branching/debranching cycle to replenish Arp2/3 complex and actin pools to promote invadopodia actin dynamics and cancer cell invasion. Overall, our data suggest that CORO1B and CORO1C function together in the mechanism of invadopodia formation and in matrix remodeling. Yet, the reason for the specific association of CORO1C up-regulation -and not CORO1B-with cancer aggressiveness is unclear, we cannot rule out some additional function of CORO1C related to its association with cancer aggressiveness.
Invadopodia's role in matrix degradation has been experimentally established, however, the existence and physiological relevance of invadopodia in cancer is questionable because of a lack of direct evidence in vivo. Yet, recent studies provided convincing evidence that invadopodia formation is essential for extravasation and intravasation of tumor cells and promotes lung metastasis in mice [9, 10, 52] . Reports based on intravital imaging of tumor cells expressing fluorescently-tagged markers documented the existence of cytoplasmic protrusions identified as invadopodia based on CTTN, N-WASP, or TKS5 enrichment and that correlated with cancer cell intra-or extravasation in vivo [9, 10] . Importantly, intravital imaging of mammary tumor xenografts of GFP CORO1C-expressing MDA-MB-231 or MCF10DCIS.com cells revealed the presence of GFP CORO1C accumulations adjacent to collagen fibers in the tumor microenvironment. However, evidence that these structures are proteolytically active is lacking and we cannot formally conclude that GFP CORO1C accumulations represent bona fide invadopodia in vivo. Noticeably, GFP CORO1C-positive structures were observed both in mesenchymal MDA-MB-231 cells and in strands of invasive epithelial MCF10DCIS.com cells supporting the implication of CORO1C in mesenchymal and collective invasion programs.
Branched actin networks also exist on intracellular compartments including endolysosomes where their main function is to sculpt and stabilize endosomal membrane microdomains involved in cargo sorting and recycling [34, 35, 53] . Endosomal actin patches are nucleated by the Arp2/3-complex upon WASH-mediated activation [34, 35] . Earlier on, we found that the WASH complex localizes to MT1-MMP-containing LE/lysosomes and its function is required for MT1-MMP trafficking to invadopodia [8] . In addition, several groups reported that depletion of WASH led to enlargement and massive tubulation of the endolysosomal system supporting the idea that WASH-dependent actin assembly may regulate the fission of endosomal recycling tubules [34, 35, 54] . CTTN was also found to associate with and regulate endosomal actin puncta on MT1-MMP-positive LE/lysosomes, and it was reported that CTTN loss or deregulation led to the accumulation of enlarged LE/lysosomes and defective endosomal traffic [8, 23, 37, 55] . The present study provides corroborating evidence that in the absence of CORO1C, endolysosomal compartments dramatically enlarged and collapsed in the perinuclear cell area. It has been argued that deficient cargo exit exemplified by massive cholesterol accumulation and organelle obstruction may lead to endosome enlargement [54] . Alteration of the endosomal actin coat may induce endosomal collapse possibly through uncontrolled fusion of individual endosomes. This assumption is supported by findings that interfering with endosomal actin regulatory components such as WASH, CTTN, CORO1A, or -C lead to perinuclear redistribution and collapse of endolysosomal compartments [34] [35] [36] [37] 54] (this study).
Moreover, we previously found that the related JIP3 and JIP4 scaffolding proteins regulate the recruitment of minusend and plus-end microtubule motor complexes to WASHpositive domains [32] . Loss of JIP3 and JIP4 proteins led to the accumulation of MT1-MMP compartments at the cell periphery, indicating unbalanced minus/plus-end motor activities (at minus-end dynein expense) [32] . Here we found that loss of CORO1C moderately increases JIP3/JIP4 recruitment on MT1-MMP-positive endosomes although the underlying mechanism remains unknown. Interestingly, enhanced recruitment of JIP4 to endolysosomal compartments was recently shown to induce endolysome collapse into the cell center [56] . Excess JIP3/JIP4 on MT1-MMP endosomes is expected to promote their perinuclear accumulation due to increased dynein activity, possibly favoring endosome collision and collapse. In agreement with this assumption, we found that formation of endosomal clusters upon loss of CORO1C was abrogated when JIP3/JIP4 were silenced. Also to be considered, coordinated functions of coronins and CTTN were also implicated in the regulation of endolysosome docking with the plasma membrane and exocytosis [37, 38] . All together, our work highlights a molecular framework based on interplay of WASH, CTTN, CORO1C, and JIP3/JIP4 function in the regulation of endosome positioning and dynamics as an essential component of MT1-MMP-based metastatic program.
Materials and methods
Cell culture
MDA-MB-231 cells (ATCC HTB-26) were grown in L15 medium supplemented with 15% fetal calf serum and 2 mM glutamine at 37°C in 1% CO 2 . MCF10DCIS.com cell line was purchased from Asterand and maintained in DMEM-F12 medium with 5% horse serum. MDA-MB-231 and MCF10DCIS.com cell lines were checked monthly for mycoplasma contamination using a real-time PCR method (MYCOPLASMACHECK, GATC Biotech AG).
Stable and transient transfection and siRNA treatment
MDA-MB-231 cells stably expressing MT1-MMP mCh have been previously described [57] . Lentiviral constructs encoding GFP CORO1C or GFP CORO1C R28D/2KE [41] cloned in pLKO.1 vector have been described [29] . MDA-MB-231 cells expressing Coro1C were generated by lentiviral transduction as described [58] . pLL7.0-m1B-EGFP construct encoding CORO1B GFP was provided by J.E. Bear. For transient expression, MDA-MB-231 cells were transfected with plasmid constructs using AMAXA nucleofection (Lonza). Cells were analyzed by live cell imaging 24-48 h after transfection. For knockdown, MDA-MB-231 cells were treated with the indicated siRNA (50 nM, see Table S1 ) using Lullaby (OZ Biosciences) and analyzed 72 h after treatment.
Antibodies and reagents
Antibodies used for this study are listed in Table S2 . GM6001 (Millipore) was diluted in ethanol and used at a concentration of 40 μM. Filipin III (stock in DMSO, 0.1 mg/ ml μM working concentration) and U18666A (stock in H 2 0, 10 μM working concentration) were purchased from Sigma.
Indirect immunofluorescence microscopy
Samples were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and then incubated with specific antibodies (see Table S2 ). For quantification of CTTN or JIP4 on MT1-MMP mCh -containing endosomes, cells were stained with specific antibodies and z-dimension series of images (z-stacks) were acquired with 0.2 µm interval with a wide-field Eclipse 90i Upright Microscope (Nikon) by mean of a piezoelectric motor (Physik Instrument), a 100x Plan Apo VC 1.4 oil immersion objective and a cooled interlined charge-coupled device (CCD) camera (CoolSnap HQ2, Roper Scientific). Images were deconvolved [59] , and detection of CTTN or JIP4 on MT1-MMP mCh -containing endosomes from the median plane of the z-stack was performed using a CellProfiler pipeline as previously described [23, 60] . Briefly, MT1-MMPmChcontaining endosomes were identified by thresholding and intensity-based watershed; CTTN or JIP4 spots in a threepixel wide neighborhood around each MT1-MMP mCh -positive vesicle were identified using a Laplacian of Gaussian filter followed by a watershed on the automatically thresholded image. Finally, the total area of CTTN or JIP4 spots was normalized over the total of MT1-MMPmCh-positive vesicles.
Live cell spinning disk confocal microscopy 
Analysis of endosome distribution and clustering
For the analysis of the distribution of MT1-MMP mCh -positive endosomes, a MATLAB software has been developed to determine the relative position of each endosome to the cell centroid as previously described [61] .
Invadopodia formation assay
Coverslips were layered with 100 µl of a 2.2 mg/ml solution of acid-extracted type I rat tail collagen (Corning) mixed with AlexaFluor 647-conjugated type I collagen (5% final). After gelling for 3 min at 37°C, the collagen layer was washed gently in PBS and 1 ml of cell suspension (10 5 cells/ml) was added. Cells were incubated for 90 min at 37°C in 1% CO 2 incubator, then pre-extracted with 0.5% Triton X-100 in 4% paraformaldehyde in PBS during 90 s and fixed in 4% paraformaldehyde in PBS for 20 min. Cells were analyzed by immunofluorescence staining with TKS5 and CTTN antibodies (Table S2) , and z-stacks of images were acquired as described above. For quantification of TKS5 associated with curvilinear invadopodia, five consecutive planes corresponding to the plasma membrane in contact with collagen fibers were projected and surface covered by TKS5 signal was determined using the thresholding command of ImageJ excluding regions <8 pixels (i.e.,<1 µm) to avoid non-invadopodial structures. Surface covered by TKS5 was normalized to the total cell surface and values normalized to control cells.
Quantification of pericellular collagenolysis
Cells were trypsinized and resuspended in 0.2 ml of 2.2 mg/ml ice-cold collagen I solution in 1x MEM, pH 7.5 buffer (2.5 × 10 5 cells/ml). A 40 µl-drop of the cell suspension in collagen was added on a 18-mm diameter glass coverslip and collagen polymerization was induced by incubation at 37°C for 30 min. Complete medium was added, and the collagen-embedded cells were incubated for 12 h at 37°C. Samples were fixed in 4% paraformaldehyde in PBS at 37°C for 30 min, and incubated with Col1-3/4 C antibody (2.5 µg/ml) for 2 h at 4°C, washed extensively with PBS and counterstained with Cy3-conjugated antirabbit IgG antibodies and with DAPI. Image acquisition was performed with an A1R Nikon confocal microscope with a 40× NA 1.3 oil objective using high-sensitivity GaASP PMT detector and a 595 ± 50 nm band-pass filter for red fluorescence detection. Quantification of the degradation spots was performed as previously described [8] .
Electron microscopy
Cells were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer and processed for EPON embedding and ultrathin sections as described [62] . For cryoimmunolabeling, cells were fixed in a mixture of 2% paraformaldehyde and 0.125% glutaraldehyde in a 0.1 M phosphate buffer pH 7.4 during 48 h [62] . Ultrathin sections were prepared with an ultracryomicrotome Leica EM UC7 and underwent single immunogold labeling with protein A conjugated to 10-nm diameter gold particles (Cell Microscopy Center, Department of Cell Biology, Utrecht University). Samples were analyzed with a Tecnai Spirit electron microscope (FEI Company, Eindhoven Netherlands) and digital acquisitions were made with a QUEMESA CCD camera (EMSIS GmbH, Münster, Germany).
Statistics and reproducibility
GraphPad Prism (GraphPad Software) was used for statistical analysis. Sample size was chosen based on estimates from pilot experiments and our published results such that appropriate statistical tests could yield significant results. Data were tested for normal distribution using the D'Agostino-Pearson normality test and nonparametric tests were applied otherwise as indicated in the figure legends. Statistical significance was defined as *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; ns, not significant. Relationships between protein expression and distribution in tumors vs. normal adjacent tissues were estimated using two tailed Student's t-test and KruskalWallis test (for links between qualitative and quantitative parameters). MFS was determined as the interval between initial diagnosis and detection of the first metastasis. Survival distributions were estimated by the Kaplan-Meier method, and the significance of differences between survival rates were ascertained with the log-rank test. The Cox proportional hazards regression model was used to assess prognostic significance, and the results are presented as hazard ratio and 95% confidence interval. The following variables were included in the analysis: SBR grade, lymph node status, macroscopic tumor size, PR status (all the classical variables with a P value under 0.10 in univariate analysis) and CORO1C or combined CORO1C and MT1-MMP mRNA expression. For animal studies, no animals were excluded from analyses and no blinding procedure was used. See Supplementary Materials and Methods for additional cell lines, western blot analysis, patient cohort for mRNA analysis, RT-qPCR analysis, patient biopsies for western blot analysis, Immunohistochemistry analysis of human breast biopsies, Mammary fat pad and intraductal injections, Mammary imaging window surgical implantation and nearinfrared multiphoton microscopy of mammary tumor xenografts.
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